Trials / Recruiting
RecruitingNCT06295588
Clinical Trial of the Seaweed Supplement Fucoidan in Survivors of Cancer
Minimizing Fatigue and Inflammation in Survivors of Cancer: A Pilot Randomized Clinical Trial of the Seaweed Supplement Fucoidan
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- University of Rochester · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To determine the feasibility of an 8-week fucoidan supplement intervention for patients with fatigue post-cancer treatment and assess changes in fatigue, frailty, and inflammation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fucoidan extracted from F. Vesiculosus | 4 g daily |
| DRUG | Fucoidan extracted from U. Pinnatifida | 4 g daily |
Timeline
- Start date
- 2025-07-26
- Primary completion
- 2026-12-31
- Completion
- 2027-06-01
- First posted
- 2024-03-06
- Last updated
- 2025-11-26
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06295588. Inclusion in this directory is not an endorsement.